In the present study, we show that targeting PSMD14 may evade the mechanisms through which cancer cells acquire resistance to Bz, a PI targeting 20S proteasome CP, such as the aggresome formation and Nrf1 activation [30,31]. Here, NRF1 is linked to cancer.